CS logo
small CS logo
Quotient Sciences

Nottingham, United Kingdom
Pharmaceutical company in Ruddington, England
Mere Way, Ruddington, Nottingham NG11 6JS

About Quotient Sciences


"Our Manifesto Where science and agility integrate and combine. Cutting through silos across a range of drug development capabilities. Saving precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
8
Boehringer Ingelheim
3
Bristol-Myers Squibb
3
MODAG GmbH
3
Balance Therapeutics
2
Bial - Portela C S.A.
2
BioCryst Pharmaceuticals
2
Boston Pharmaceuticals
2
Drugs for Neglected Diseases
2
Flatley Discovery Lab LLC
2
Galapagos NV
2
Total Rows: 46

Clinical Trials at Quotient Sciences


During the past decade, Quotient Sciences conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 5 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 4 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years667712125512127799440000001100220000Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®
2011-12-01
2012-06-01
Completed
12
ITF2984 Repeated Doses Study in Healthy Volunteers
2012-01-01
2013-05-01
Completed
46
Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
2013-11-01
2013-12-01
Completed
7
Absolute Bioavailability Of Bosutinib
2014-08-01
2014-10-01
Completed
14
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
2014-12-01
2016-04-01
Completed
94
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers
2015-05-01
2015-12-01
Completed
122
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143
2015-06-29
2017-02-24
Completed
35
A Safety and Tolerability Study of AG-519 in Healthy Subjects
2015-12-01
2016-12-01
Terminated
108

Rows per page:

1–67 of 67

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Quotient Sciences" #1 sponsor was "Genentech, Inc." with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "MODAG GmbH" with 3 trials sponsored and "Balance Therapeutics" with 3 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 46 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Quotient Sciences" #1 collaborator was "Quotient Sciences" with 12 trials as a collaborator, "Quotient Clinical" with 6 trials as a collaborator, "Aptuit" with 3 trials as a collaborator, "Banook Group" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGenentech, Inc.: 8Genentech, Inc.: 8Boehringer Ingelheim: 3Boehringer Ingelheim: 3Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3MODAG GmbH: 3MODAG GmbH: 3Balance Therapeutics: 2Balance Therapeutics: 2Bial - Portela C S.A.: 2Bial - Portela C S.A.: 2BioCryst Pharmaceuticals: 2BioCryst Pharmaceuticals: 2Boston Pharmaceuticals: 2Boston Pharmaceuticals: 2Drugs for Neglected Diseases: 2Drugs for Neglected Diseases: 2Flatley Discovery Lab LLC: 2Flatley Discovery Lab LLC: 2

Created with Highcharts 11.1.0Top CollaboratorsQuotient Sciences: 12Quotient Sciences: 12Quotient Clinical: 6Quotient Clinical: 6Aptuit: 3Aptuit: 3Banook Group: 1Banook Group: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Inncelerex: 1Inncelerex: 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1Nottingham UniversityHospitals NHS Trust: 1Nottingham UniversityHospitals NHS Trust: 1Swiss Bio Quant: 1Swiss Bio Quant: 1Teva PharmaceuticalIndustries, Ltd.: 1Teva PharmaceuticalIndustries, Ltd.: 1

Clinical Trials Conditions at Quotient Sciences


According to Clinical.Site data, the most researched conditions in "Quotient Sciences" are "Healthy" (12 trials), "Healthy Volunteers" (12 trials), "Healthy Volunteer" (4 trials), "Cystic Fibrosis" (2 trials) and "Healthy Participants" (2 trials). Many other conditions were trialed in "Quotient Sciences" in a lesser frequency.

Clinical Trials Intervention Types at Quotient Sciences


Most popular intervention types in "Quotient Sciences" are "Drug" (66 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Rabeprazole" (3 trials), "GDC-0853" (2 trials), "Midazolam" (2 trials) and "anle138b" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Quotient Sciences


The vast majority of trials in "Quotient Sciences" are 33 trials for "All" genders, 30 trials for "Male" genders and 4 trials for "Female" genders.

Clinical Trials Status at Quotient Sciences


Currently, there are NaN active trials in "Quotient Sciences". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Quotient Sciences, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Quotient Sciences, 66 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 66Phase 1: 66Early Phase 1: 1Early Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 58Completed: 58Terminated: 4Terminated: 4Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1